table of content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Thin Film Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Oral Thin Film Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Sublingual Film
1.4.3 Fully Dissolving Dental/Buccal Film
1.5 Market by Application
1.5.1 Global Oral Thin Film Drugs Market Share by Application: 2022-2027
1.5.2 Schizophrenia
1.5.3 Migraine
1.5.4 Opioid Dependence
1.5.5 Nausea & Vomiting
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Oral Thin Film Drugs Market
1.8.1 Global Oral Thin Film Drugs Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Oral Thin Film Drugs Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Oral Thin Film Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oral Thin Film Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oral Thin Film Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Oral Thin Film Drugs Sales Volume Market Share by Region (2016-2021)
3.2 Global Oral Thin Film Drugs Sales Revenue Market Share by Region (2016-2021)
3.3 North America Oral Thin Film Drugs Sales Volume
3.3.1 North America Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.3.2 North America Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Oral Thin Film Drugs Sales Volume
3.4.1 East Asia Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Oral Thin Film Drugs Sales Volume (2016-2021)
3.5.1 Europe Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Oral Thin Film Drugs Sales Volume (2016-2021)
3.6.1 South Asia Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Oral Thin Film Drugs Sales Volume (2016-2021)
3.7.1 Southeast Asia Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Oral Thin Film Drugs Sales Volume (2016-2021)
3.8.1 Middle East Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Oral Thin Film Drugs Sales Volume (2016-2021)
3.9.1 Africa Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Oral Thin Film Drugs Sales Volume (2016-2021)
3.10.1 Oceania Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Oral Thin Film Drugs Sales Volume (2016-2021)
3.11.1 South America Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.11.2 South America Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Oral Thin Film Drugs Sales Volume (2016-2021)
3.12.1 Rest of the World Oral Thin Film Drugs Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Oral Thin Film Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Oral Thin Film Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Oral Thin Film Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Oral Thin Film Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Oral Thin Film Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Oral Thin Film Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Oral Thin Film Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Oral Thin Film Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Oral Thin Film Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Oral Thin Film Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Oral Thin Film Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Oral Thin Film Drugs Sales Volume Market Share by Type (2016-2021)
14.2 Global Oral Thin Film Drugs Sales Revenue Market Share by Type (2016-2021)
14.3 Global Oral Thin Film Drugs Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Oral Thin Film Drugs Consumption Volume by Application (2016-2021)
15.2 Global Oral Thin Film Drugs Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Oral Thin Film Drugs Business
16.1 Sumitomo Dainippon Pharma Co., Ltd.
16.1.1 Sumitomo Dainippon Pharma Co., Ltd. Company Profile
16.1.2 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Product Specification
16.1.3 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Pfizer
16.2.1 Pfizer Company Profile
16.2.2 Pfizer Oral Thin Film Drugs Product Specification
16.2.3 Pfizer Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Novartis AG
16.3.1 Novartis AG Company Profile
16.3.2 Novartis AG Oral Thin Film Drugs Product Specification
16.3.3 Novartis AG Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 ZIM Laboratories Limited
16.4.1 ZIM Laboratories Limited Company Profile
16.4.2 ZIM Laboratories Limited Oral Thin Film Drugs Product Specification
16.4.3 ZIM Laboratories Limited Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Indivior Plc.
16.5.1 Indivior Plc. Company Profile
16.5.2 Indivior Plc. Oral Thin Film Drugs Product Specification
16.5.3 Indivior Plc. Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Allergan Plc.
16.6.1 Allergan Plc. Company Profile
16.6.2 Allergan Plc. Oral Thin Film Drugs Product Specification
16.6.3 Allergan Plc. Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 IntelGenx Corp
16.7.1 IntelGenx Corp Company Profile
16.7.2 IntelGenx Corp Oral Thin Film Drugs Product Specification
16.7.3 IntelGenx Corp Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 NAL Pharma
16.8.1 NAL Pharma Company Profile
16.8.2 NAL Pharma Oral Thin Film Drugs Product Specification
16.8.3 NAL Pharma Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Wolters Kluwer
16.9.1 Wolters Kluwer Company Profile
16.9.2 Wolters Kluwer Oral Thin Film Drugs Product Specification
16.9.3 Wolters Kluwer Oral Thin Film Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Oral Thin Film Drugs Manufacturing Cost Analysis
17.1 Oral Thin Film Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Oral Thin Film Drugs
17.4 Oral Thin Film Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Oral Thin Film Drugs Distributors List
18.3 Oral Thin Film Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Oral Thin Film Drugs (2022-2027)
20.2 Global Forecasted Revenue of Oral Thin Film Drugs (2022-2027)
20.3 Global Forecasted Price of Oral Thin Film Drugs (2016-2027)
20.4 Global Forecasted Production of Oral Thin Film Drugs by Region (2022-2027)
20.4.1 North America Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.3 Europe Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.7 Africa Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.9 South America Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Oral Thin Film Drugs Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Oral Thin Film Drugs by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Oral Thin Film Drugs by Country
21.2 East Asia Market Forecasted Consumption of Oral Thin Film Drugs by Country
21.3 Europe Market Forecasted Consumption of Oral Thin Film Drugs by Countriy
21.4 South Asia Forecasted Consumption of Oral Thin Film Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Oral Thin Film Drugs by Country
21.6 Middle East Forecasted Consumption of Oral Thin Film Drugs by Country
21.7 Africa Forecasted Consumption of Oral Thin Film Drugs by Country
21.8 Oceania Forecasted Consumption of Oral Thin Film Drugs by Country
21.9 South America Forecasted Consumption of Oral Thin Film Drugs by Country
21.10 Rest of the world Forecasted Consumption of Oral Thin Film Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
